InVivo Therapeutics, Paradigm Spine, Aurora Spine & more: 9 key notes

Spinal Tech

Here are nine key notes on orthopedic and spine device companies over the past week.

Melanie Morel-Ferris, CPA, will become Cambridge, Mass.-based InVivo Therapeutics' interim CFO, effective Jan. 2, 2017.

 

Plainsboro, N.J.-based Integra LifeSciences appointed three new executives, effective Dec. 1, 2016. They are:

 

•    Robert T. Davis, Jr., who will serve as the company's corporate vice president and president of Orthopedic and Tissue Technologies.
•    Dan Reuvers, who will serve as the new corporate vice president and president of Specialty Surgical Solutions.
•    Glenn Coleman, who will now oversee the company's international business, in addition to his current role as corporate vice president, CFO and principal accounting officer.

 

The International Society for the Advancement of Spine Surgery issued a policy statement recommending coverage of decompression with interlaminar stabilization, which noted the benefits provided by Paradigm Spine's coflex Interlaminar Stabilization device compared to fusion.

 

Germany-based curasan received FDA clearance to market its CERASORB Ortho FOAM.


 
Carlsbad, Calif.-based Aurora Spine created a mobile app designed to provide information on the company's products.

 

Lyon, France-based Medicrea will host a key opinion leader breakfast for investors to discuss the personalized spine market.

 

Collins, Colo.-based Green Sun Medical's dynamic spinal alignment brace won second place at the 2016 HITLAB World Cup, an international digital health challenge.

 

The FDA cleared San Diego-based Kyocera Medical Corp.'s Initia Total Hip System.


 
Analysts gave Caesarea, Israel-based Mazor Robotics an average rating of "hold."

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.